Vytorin is Ineffective, Overly Expensive and May Cause Cancer

Vytorin is Ineffective, Overly Expensive and May Cause Cancer

(00:02:22)

Vytorin is a prescription drug marketed by Merck and Shering-Plough for treating high cholesterol.  Vytorin has recently come under incredible scrutiny as new information shows that the drug is ineffective, incredibly expensive and may actually cause cancer.

Recorded: Tuesday, November 4, 2008

Courtesy of: Beasley Allen Video

Keywords: Pharmaceutical, Vytorin



blog comments powered by Disqus

Comments are moderated and generally will be posted if they are on-topic and not abusive.